| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sirichai Chayasirisobho. The Role of Cannabidiol in Neurological Disorders. The Permanente journal. vol 25. 2021-10-15. PMID:33970090. |
cannabinoids are compounds in cannabis that are known to have therapeutic potential. |
2021-10-15 |
2023-08-13 |
Not clear |
| Sirichai Chayasirisobho. The Role of Cannabidiol in Neurological Disorders. The Permanente journal. vol 25. 2021-10-15. PMID:33970090. |
the most abundant chemicals in cannabinoids are delta-9-tetrahydrocannabinol and cannabidiol. |
2021-10-15 |
2023-08-13 |
Not clear |
| Catherine F Moore, Elise M Weert. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations. Psychopharmacology. 2021-10-15. PMID:34652500. |
cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (thc) and cannabidiol (cbd) in male and female rats: sex, dose-effects and time course evaluations. |
2021-10-15 |
2023-08-13 |
rat |
| Matheus Perez, Luciana Politti Cartarozzi, Gabriela Bortolança Chiarotto, Francisco Silveira Guimarães, Alexandre Leite Rodrigues de Oliveir. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy. Neuropharmacology. vol 197. 2021-10-14. PMID:34303725. |
the present study aimed to investigate the neuroprotective potential of cannabidiol (cbd) and the role of cannabinoid receptors after sciatic nerve crush in neonatal rats. |
2021-10-14 |
2023-08-13 |
rat |
| Luis Vitetta, Belinda Butcher, Jeremy D Henson, David Rutolo, Sean Hal. A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study. Inflammopharmacology. vol 29. issue 5. 2021-10-14. PMID:34357480. |
the cannabis plant presents a complex biochemical unit of over 500 constituents of which 70 or more molecules have been classified as cannabinoids binding to cannabinoid receptors. |
2021-10-14 |
2023-08-13 |
Not clear |
| F Mitchell Westmoreland, Paul Kusuma, Bruce Bugbe. Cannabis lighting: Decreasing blue photon fraction increases yield but efficacy is more important for cost effective production of cannabinoids. PloS one. vol 16. issue 3. 2021-10-13. PMID:33755709. |
cannabis lighting: decreasing blue photon fraction increases yield but efficacy is more important for cost effective production of cannabinoids. |
2021-10-13 |
2023-08-13 |
Not clear |
| Virginia Brighenti, Lucia Marchetti, Lisa Anceschi, Michele Protti, Patrizia Verri, Federica Pollastro, Laura Mercolini, Davide Bertelli, Chiara Zanardi, Federica Pellat. Separation and non-separation methods for the analysis of cannabinoids in Cannabis sativa L. Journal of pharmaceutical and biomedical analysis. vol 206. 2021-10-13. PMID:34537622. |
separation and non-separation methods for the analysis of cannabinoids in cannabis sativa l. cannabis sativa l. is a plant known all over the world, due to its history, bioactivity and also social impact. |
2021-10-13 |
2023-08-13 |
Not clear |
| Theodore J Wite. Please don't call it medical marijuana unless it is; but it probably isn't. Canadian journal of public health = Revue canadienne de sante publique. vol 112. issue 1. 2021-10-12. PMID:32557287. |
to distill the potential medical benefits through the pharmacologic understanding of the endocannabinoid system, cannabis should follow the traditional drug development process or one that improves upon it. |
2021-10-12 |
2023-08-13 |
Not clear |
| Antonio Franco-Vadillo, Mireille Toledo-Blass, Zeltzin Rivera-Herrera, Gustavo Guevara-Balcazar, Oscar Orihuela-Rodriguez, Jose A Morales-Carmona, Alexandre Kormanovski-Kovzova, Pedro Lopez-Sanchez, Ivan Rubio-Gayosso, Maria Del Carmen Castillo-Hernande. Cannabidiol-mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage. Pharmacology research & perspectives. vol 9. issue 4. 2021-10-12. PMID:34176244. |
there are many cardioprotective agents; within these, cannabinoids have shown to have beneficial effects, mainly cannabidiol (cbd). |
2021-10-12 |
2023-08-13 |
rat |
| Pedro G Vásquez-Ocmín, Guillaume Marti, Maxime Bonhomme, Fabienne Mathis, Sylvie Fournier, Stéphane Bertani, Alexandre Maciu. Cannabinoids vs. whole metabolome: Relevance of cannabinomics in analyzing Cannabis varieties. Analytica chimica acta. vol 1184. 2021-10-12. PMID:34625242. |
cannabinoids vs. whole metabolome: relevance of cannabinomics in analyzing cannabis varieties. |
2021-10-12 |
2023-08-13 |
Not clear |
| Mariia Zaiachuk, Nazar Pryimak, Olga Kovalchuk, Igor Kovalchu. Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy. Frontiers in medicine. vol 8. 2021-10-12. PMID:34631734. |
cannabinoids, medical cannabis, and colorectal cancer immunotherapy. |
2021-10-12 |
2023-08-13 |
Not clear |
| Florence Thibaut, Margret R Hoeh. Cannabinoids: for better and for worse
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162763. |
thus, despite concerns about the safety of cannabis and cannabinoids, quite a few drugs that contain cannabinoids have recently been approved by several drug agencies, and the medicinal and recreational use of cannabis has been legalized in various countries and states. |
2021-10-11 |
2023-08-13 |
Not clear |
| Marc-Antoine Croc. History of cannabis and the endocannabinoid system
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162765. |
history of cannabis and the endocannabinoid system
. |
2021-10-11 |
2023-08-13 |
Not clear |
| Marc-Antoine Croc. History of cannabis and the endocannabinoid system
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162765. |
this article retraces the story of cannabis from the earliest contacts of humans with the plant to its subsequent global expansion, its medicinal uses, and the discovery of the endocannabinoid system in the 20 |
2021-10-11 |
2023-08-13 |
Not clear |
| Jahan Marc. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162772. |
this brief report covers recent advances in cannabis and cannabinoid regulation and drug approval. |
2021-10-11 |
2023-08-13 |
Not clear |
| Jahan Marc. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162772. |
the popularity of cannabis and cannabinoid products continues to rise, and these products are available for the majority of the population in the united states to purchase as easily as alcohol. |
2021-10-11 |
2023-08-13 |
Not clear |
| Jahan Marc. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162772. |
multiple pathways for market approval would protect public health, whether the public is using cannabis and cannabinoids as a medicine, a wellness product, or as a recreational substance.
. |
2021-10-11 |
2023-08-13 |
Not clear |
| Veronika Kondev, Nathan Winters, Sachin Pate. Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches. International review of neurobiology. vol 157. 2021-10-11. PMID:33648669. |
furthermore, endocannabinoid deficiency states, either pre-existing or induced by trauma exposure, could provide explanatory insights into the high rates of comorbid cannabis use in patients with ptsd. |
2021-10-11 |
2023-08-13 |
Not clear |
| A A A Putri Laksmidewi, Andreas Soejitn. Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors. Journal of neural transmission (Vienna, Austria : 1996). vol 128. issue 5. 2021-10-11. PMID:33712975. |
endocannabinoid system (ecs) has been identified ever since cannabinoid, an active substance of cannabis, was known to interact with endogenous cannabinoid (endocannabinoid/ecb) receptors. |
2021-10-11 |
2023-08-13 |
human |
| H V Kosiakova, S A Chumak, A G Berdyshev, I Ya Pinchuk, N M Hula, A A Chuma. RADIATION DAMAGE OF THE NERVOUS SYSTEM AND ENDOCANABINOIDS. Problemy radiatsiinoi medytsyny ta radiobiolohii. vol 25. 2021-10-08. PMID:33361830. |
the participation of the endocannabinoid system in ensuring homeostasis andpathology formation, potential possibilities of using cannabis drugs, agonists and antagonists of endocannabinoidreceptors for the treatment of early and long-term effects of radiation are considered. |
2021-10-08 |
2023-08-13 |
Not clear |